Molecular Mechanisms Underlying Muscle Wasting in Huntington's Disease

Area of Science:

• Neurodegenerative disorders
• Genetics and molecular biology
• Muscle physiology

Background:

• Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder.
• It stems from CAG triplet expansions in the Huntingtin gene, causing protein misfolding and aggregation.
• HD affects the central nervous system, leading to neurological and motor deficits, alongside body weight loss and muscle atrophy.

Purpose of the Study:

• To review key factors contributing to muscle atrophy in Huntington's disease.
• To emphasize the importance of understanding muscle deterioration mechanisms in HD.
• To highlight the potential therapeutic benefits of improving muscular symptoms.

Main Methods:

• Literature review focusing on molecular mechanisms of muscle atrophy in HD.
• Analysis of studies examining transcriptional alterations, mitochondrial dysfunction, inflammation, apoptosis, and protein quality control in HD muscle.
• Synthesis of findings from animal models demonstrating the impact of muscular symptom improvement on disease progression.

Main Results:

• Muscle atrophy in HD is linked to altered transcriptional processes.
• Mitochondrial dysfunction, impaired energy homeostasis, inflammation, and apoptosis are significant contributors.
• Defects in protein quality control mechanisms exacerbate muscle wasting in HD.

Conclusions:

• Understanding the molecular underpinnings of muscle atrophy is crucial for HD management.
• Interventions targeting muscle health may slow disease progression and improve lifespan in HD.
• Further research into these mechanisms could reveal novel therapeutic strategies for Huntington's disease.